Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I10E versus Kiovig in multifocal motor neuropathy
2012-001995-12Phase 3Completed
- Sponsor
- LFB Group
- Start
- Mar 2013
- Modality
- Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of IqYmune, kiovig in multifocal motor neuropathy (MMN), sponsored by LFB Group. Started Mar 2013; status: completed.
02
Drugs
IqYmunekiovig
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on 2012-001995-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001995-12.